O=C1OC[C@@H]2Cc3c([nH]c4ccccc34)[C@@H](c3cc(O)c(O)c(O)c3)N12
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?